Trinity Biotech PLC (TRIB)
1.21
-0.09
(-6.92%)
USD |
NASDAQ |
Nov 22, 12:48
Trinity Biotech Total Liabilities (Quarterly): 123.79M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 123.79M |
| June 30, 2024 | 123.76M |
| March 31, 2024 | 113.16M |
| December 31, 2023 | 83.38M |
| September 30, 2023 | 81.08M |
| June 30, 2023 | 83.37M |
| March 31, 2023 | 97.78M |
| December 31, 2022 | 94.28M |
| September 30, 2022 | 91.26M |
| June 30, 2022 | 91.32M |
| March 31, 2022 | 112.38M |
| December 31, 2021 | 119.21M |
| September 30, 2021 | 121.97M |
| June 30, 2021 | 125.22M |
| March 31, 2021 | 136.11M |
| December 31, 2020 | 132.62M |
| September 30, 2020 | 129.00M |
| June 30, 2020 | 129.44M |
| March 31, 2020 | 128.36M |
| December 31, 2019 | 126.36M |
| September 30, 2019 | 134.32M |
| June 30, 2019 | 132.63M |
| March 31, 2019 | 128.48M |
| December 31, 2018 | 107.60M |
| September 30, 2018 | 115.24M |
| Date | Value |
|---|---|
| June 30, 2018 | 127.76M |
| March 31, 2018 | 128.90M |
| December 31, 2017 | 127.78M |
| September 30, 2017 | 138.24M |
| June 30, 2017 | 137.93M |
| March 31, 2017 | 135.86M |
| December 31, 2016 | 140.86M |
| September 30, 2016 | 150.07M |
| June 30, 2016 | 147.11M |
| March 31, 2016 | 147.56M |
| December 31, 2015 | 149.79M |
| September 30, 2015 | 144.38M |
| June 30, 2015 | 154.70M |
| March 31, 2015 | 45.54M |
| December 31, 2014 | 45.87M |
| September 30, 2014 | 42.22M |
| June 30, 2014 | 42.34M |
| March 31, 2014 | 39.90M |
| December 31, 2013 | 43.48M |
| September 30, 2013 | 47.75M |
| June 30, 2013 | 28.63M |
| March 31, 2013 | 28.78M |
| December 31, 2012 | 28.03M |
| September 30, 2012 | 24.85M |
| June 30, 2012 | 24.28M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
81.08M
Minimum
Sep 2023
136.11M
Maximum
Mar 2021
112.19M
Average
120.59M
Median
Total Liabilities (Quarterly) Benchmarks
| Amarin Corp PLC | 219.24M |
| DBV Technologies SA | 39.02M |
| Ascendis Pharma AS | 1.330B |
| Cellectis SA | 266.45M |
| Adaptimmune Therapeutics PLC | 237.45M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 97.45M |
| Shareholders Equity (Quarterly) | -26.34M |
| Debt to Equity Ratio | -3.106 |
| Current Ratio | 1.642 |
| Net Debt Paydown Yield | -53.20% |